These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10681527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.
    Liu ZH, Tsuchida K, Matsuzaki T, Bao YL, Kurisaki A, Sugino H.
    J Endocrinol; 2006 May; 189(2):409-21. PubMed ID: 16648306
    [Abstract] [Full Text] [Related]

  • 3. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway.
    Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H.
    J Biol Chem; 2002 May 24; 277(21):19008-18. PubMed ID: 11882656
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intracellular and extracellular control of activin function by novel regulatory molecules.
    Tsuchida K, Matsuzaki T, Yamakawa N, Liu Z, Sugino H.
    Mol Cell Endocrinol; 2001 Jun 30; 180(1-2):25-31. PubMed ID: 11451568
    [Abstract] [Full Text] [Related]

  • 7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S, Klein C, Roh J, Kaivo-Oja N, Mottershead DG, Korchynskyi O, Ritvos O, Hsueh AJ.
    Mol Endocrinol; 2004 Mar 30; 18(3):653-65. PubMed ID: 14684852
    [Abstract] [Full Text] [Related]

  • 8. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.
    Lux A, Beil C, Majety M, Barron S, Gallione CJ, Kuhn HM, Berg JN, Kioschis P, Marchuk DA, Hafner M.
    J Biol Chem; 2005 Mar 04; 280(9):8482-93. PubMed ID: 15611116
    [Abstract] [Full Text] [Related]

  • 9. Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells.
    Qi Y, Ge JY, Wang YN, Liu HY, Li YM, Liu ZH, Cui XL.
    Neurosci Lett; 2013 May 10; 542():53-8. PubMed ID: 23523645
    [Abstract] [Full Text] [Related]

  • 10. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB.
    EMBO J; 2003 Sep 01; 22(17):4465-77. PubMed ID: 12941698
    [Abstract] [Full Text] [Related]

  • 11. The RIM/NIM family of neuronal C2 domain proteins. Interactions with Rab3 and a new class of Src homology 3 domain proteins.
    Wang Y, Sugita S, Sudhof TC.
    J Biol Chem; 2000 Jun 30; 275(26):20033-44. PubMed ID: 10748113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, Mauviel A.
    Oncogene; 2002 Jul 25; 21(32):4879-84. PubMed ID: 12118366
    [Abstract] [Full Text] [Related]

  • 14. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
    Nagarajan RP, Liu J, Chen Y.
    J Biol Chem; 1999 Oct 29; 274(44):31229-35. PubMed ID: 10531318
    [Abstract] [Full Text] [Related]

  • 15. Three isoforms of synaptic scaffolding molecule and their characterization. Multimerization between the isoforms and their interaction with N-methyl-D-aspartate receptors and SAP90/PSD-95-associated protein.
    Hirao K, Hata Y, Yao I, Deguchi M, Kawabe H, Mizoguchi A, Takai Y.
    J Biol Chem; 2000 Jan 28; 275(4):2966-72. PubMed ID: 10644767
    [Abstract] [Full Text] [Related]

  • 16. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
    Tsuchida K, Mathews LS, Vale WW.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11242-6. PubMed ID: 8248234
    [Abstract] [Full Text] [Related]

  • 17. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N, Mottershead DG, Mazerbourg S, Myllymaa S, Duprat S, Gilchrist RB, Groome NP, Hsueh AJ, Ritvos O.
    J Clin Endocrinol Metab; 2005 Jan 01; 90(1):271-8. PubMed ID: 15483083
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec 01; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 19. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.
    Blobe GC, Liu X, Fang SJ, How T, Lodish HF.
    J Biol Chem; 2001 Oct 26; 276(43):39608-17. PubMed ID: 11546783
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T, Moustakas A, Lin HY, Lodish HF.
    Exp Cell Res; 1995 Jan 26; 216(1):208-14. PubMed ID: 7813622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.